End stage multiple myeloma is the final stage of advanced multiple myeloma. According to MedlinePlus, the symptoms of end stage multiple myeloma include vomiting, nausea, urination problems, numbness in legs and constipation.Know More
Multiple myeloma often times originates in the bone marrow and is similar to diseases such as leukemia and lymphoma. WebMD states that currently there is no cure for multiple myeloma and that the treatments move slowly in dealing with the disorder. During the early stages of multiple myeloma, no symptoms may be apparent. As the disease begins to move forward, symptoms include weight loss, kidney problems, bone pain due to lytic bone disease, anemia, confusion, excessive thirst from hypercalcemia, and infections. In rare cases, purple masses, known as extramedullary plasmacytomas, can develop beneath the skin.
According to WebMD, risk factors that can make people more vulnerable to multiple myeloma include being male, over 65 years of age, African-American, and having family members who have been afflicted by the disease. Those that have been diagnosed with solitary plasmacytoma, or monoclonal gammopathy of uncertain significance (MGUS), are also at risk for developing mutlple myeloma. During lab tests, indicators of multiple myeloma are anemia, protein in urine, elevated creatine, and high blood calcium.Learn more about Cancer
Oncolytic virotherapy used on patients with stage 4 multiple myeloma suggest that, at least for some patients, it is possible to survive stage 4 or “end-stage” multiple myeloma. Mayo Clinic researchers using laboratory-engineered measles viruses reported a high percentage of tumor regression in clinical trials in 2014.Full Answer >
The survival rates for multiple myeloma are 62, 44 and 29 months for stages one, two and three, respectively, according to Cancer.org. Physicians use survival rates for multiple myeloma, a type of cancer that affects plasma cells, to gauge a patient’s outlook or prognosis.Full Answer >
According to the American Cancer Society, there are three stages of multiple myeloma. Stage one is characterized by a relatively small presence of myeloma cells, stage two is characterized by a moderate number of myeloma cells, and stage three is characterized with a large volume of cancerous cells.Full Answer >
The life expectancy for someone with multiple myeloma depends on the stage of the disease when diagnosed, according to the American Cancer Society. Stage I patients have a median survival rate of 62 months. Stage II patients have a life expectancy of 44 months, and stage III is 29 months.Full Answer >